Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
437,636
-
Share change
-
+437,636
-
Total reported value
-
$1,737,305
-
Price per share
-
$3.97
-
Number of holders
-
24
-
Value change
-
+$1,737,307
-
Number of buys
-
24
Institutional Holders of Clearside Biomedical, Inc. - COM NEW (CLSDQ) as of Q3 2025
As of 30 Sep 2025,
Clearside Biomedical, Inc. - COM NEW (CLSDQ) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
437,636 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., RENAISSANCE TECHNOLOGIES LLC, FIRST MANHATTAN CO. LLC., STATE STREET CORP, GSA CAPITAL PARTNERS LLP, Apollon Wealth Management, LLC, NORTHERN TRUST CORP, and UBS Group AG.
This page lists
24
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.